ArticleFrontiers in cell and developmental biology2026
Endothelial glycocalyx glycan expression in lymphatic vasculature in mice.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Lymphatic vessels are crucial for the drainage and transport of interstitial fluids, cells, and macromolecules. Like all other cells, lymphatic endothelial cells express a cell-surface glycocalyx, composed of carbohydrate-enriched molecules, that contributes to endothelial barrier maintenance and cell-cell communication. Although the endothelial glycocalyx has been increasingly studied in blood endothelium, little has been done to characterize it in lymphatics. In this study, among a variety of tested fixatives, Carnoy's fixative, a solution of ethanol, chloroform, and acetic acid, was determined to best preserve endothelial glycocalyx epitopes in lymphatics-on-chip microfluidic devices and mouse tissue sections. Dermal, lung, and lymph node tissues were isolated from male C57BL/6J mice and fixed with Carnoy's fixative. We aimed to determine the presence of prominent glycocalyx components, including heparan sulfate and chondroitin sulfate, across different mouse organs to characterize organ-specific differences. We hypothesized that, due to the different organ environment demands for fluid clearance and immune surveillance, the expression of major glycocalyx components would be heterogeneous. However, immunofluorescence imaging of these tissues demonstrated the presence of these glycans within LYVE-1-positive structures across the tested tissues. This conclusion provides a basis for further characterization and understanding of the composition, function, and potential alterations of the lymphatic endothelial glycocalyx across very distinct organs/tissues and conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.